Aurobindo Pharma Ltd.
Search Company
Registered Address
Registered Office : Plot No.2, Maitri Vihar, Ameerpet,
Hyderabad, Telangana - 500038
Tel: 040-23736370, 23747340
Fax: 040-23741080
Email : info@aurobindo.com
Website : http://www.aurobindo.com
Key Officials
Name Designation
Mr. B Adi Reddy Co. Secretary & Compl. Officer
Mr. Santhanam Subramanian Chief Financial Officer
Listings
BSE , MCXSX , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Jun 25 Mar 25 Dec 24
Sales 2,848.17 2,731.99 2,916.63
Other Income 83.77 113.98 54.26
Total Expenses 2,037.45 2,119.17 2,184.42
Operating Profit 810.72 612.82 732.21
Interest 60.00 61.09 66.19
Gross Profit 820.11 649.40 701.22
Provisions Made 0.00 0.00 0.00
Depreciation 70.02 93.88 68.28
Taxation 190.96 147.35 160.89
Net Profit / Loss 559.13 408.17 472.05
Equity Capital 58.08 58.08 58.08
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 58.08 58.59 58.59
Reserve & Surplus 20,476.03 19,664.23 17,855.58
Revaluation Reserve 0.00 0.00 0.00
Networth 20,534.11 19,722.82 17,914.17
Total debt 4,625.09 2,817.84 4,142.57
Total Liability 25,159.20 22,540.66 22,056.74
Net Block 2,336.80 2,419.13 3,687.50
Capital work in progress 87.53 132.68 239.09
Investment 15,209.57 13,393.44 8,221.78
Net current asset 7,525.30 6,595.41 9,908.37
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 25,159.20 22,540.66 22,056.74
Income Statement
  Mar25 Mar24 Mar23
Sales 10,933.30 10,645.64 12,792.28
Other Income 328.12 616.06 433.76
Total Expenses 8,375.73 8,421.60 11,061.36
Operating Profit 2,557.57 2,224.04 1,730.92
Interest 230.04 182.60 114.98
Adjusted PBDIT 2,885.69 2,840.10 2,164.68
Depreciation 297.20 254.58 435.35
Adjusted PBT 2,358.45 2,402.92 1,614.35
Taxation 611.66 502.82 383.94
Net Profit / Loss 1,746.79 1,954.14 1,230.41
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 23.39 20.89 13.53
GPM (%) 20.67 18.50 10.12
NPM (%) 15.97 18.35 9.61
Earning Retention Ratio 100.00 86.13 64.29
Return on networth (%) 8.50 9.90 6.86
EPS (Rs.) 30.08 33.35 21.00
Dividend payout Ratio 0.00 13.49 35.71
Longterm Debt-Equity Ratio 0.01 0.00 0.00
Current Ratio 4.20 3.52 4.44
Fixed Asset Turnover Ratio 0.45 0.47 0.62
Inventory 0.43 0.47 0.57
Interest coverage Ratio 12.54 15.55 18.83
Registrar Details
KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel : 040-67161500
Fax : 23420814
BSE
Market Performance
Exchange BSE
Last Traded Price (Rs.) 1,138.65
Last Traded Date 31/10/2025
Last Traded Time -
Change (%) 3.28%
Day's Open (Rs.) 1,114.35
Previous Close (Rs.) 1,102.50
Day's High (Rs.) 1,156.00
Day's Low (Rs.) 1,101.15
Volume (Rs. In Lacs) 2611.27
Bid Price (Rs.) 0.00
Bid Quantity
Offer Price (Rs.) 0.00
Offer Quantity
Exchange Code 524804
Exchange Group A
Board Meetings
Date Purpose
05/11/2025 Quarterly Results
04/08/2025 Quarterly Results & Interim Dividend
26/05/2025 Audited Results
Corporate News
Aurobindo Pharma - Updates
Aurobindo Pharma - Clarification With Reference To Movement In Volume.
Aurobindo Pharma - Clarification sought from Aurobindo Pharma Ltd
Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Share Holding Pattern as on 30/09/2025
Major Holder No. of Shares Percentage(%)
Promoters 300,948,721 51.82
Institutional Investors 242,819,310 41.81
Other Investors 6,538,053 1.13
General Public 30,495,539 5.25